Related Experiment Video
Updated: Jan 24, 2026

An Automated Method to Perform The In Vitro Micronucleus Assay using Multispectral Imaging Flow Cytometry
Published on: May 13, 2019
The application of an in vitro micronucleus test in mouse fibroblast L929 cells
Ewa Drozd1, Irena Bubko1, Karolina Jaworska2
1Department of Biochemistry and Biopharmaceuticals, National Medicines Institute, Chełmska 30/34 Str., 00-725, Warsaw, Poland.
Abstract:
The MNa (in vitro the micronucleus assay) is recommended for studying genotoxicity of chemicals. However, no protocol is currently available for experiments with mouse fibroblast L929 cells. The aim of this study was to improve the scope of CBMNb (cytokinesis-block micronucleus) test. Optimization consisted of: selection of a non-cytotoxic concentration of cytokinesis blocker - cytoBc (cytochalasin B) and type and definition of the positive controls, verification of the efficacy of phenobarbital/5,6-benzoflavone as an S9 enzyme inducer as well as the identification of an optimal staining method. The compounds were tested in three exposure regimens: 6 h exposure with S9 activation followed by a 24 h recovery period, 6 h exposure followed by a 24 h recovery without metabolic activation of S9 and 30 h continuous exposure without S9. Different parameters, such as internal and interlaboratory reproducibility were investigated and criteria for test correctness were proposed. Higher MN rates were achieved using 1 μg/mL cytoBc as a cytokinesis blocker, and MMSd (methyl methanesulfonate), (250 μM), Cole (colchicine), (0.5 μM) and CPf (cyclophosphamide), (30 μM) as positive controls. In regard to the recommended S9 inducer, phenobarbital/5,6-benzoflavone was more effective as Aroclor 1254. Giemsa and acridine orange stains were optimal for the evaluation of MN formation. The protocol described in this study with L929 cells produced the reliable results and is suitable for performing the CBMNb experiments according to the current OECD Guideline #487.
Insights
This study optimized the in vitro micronucleus assay for mouse L929 cells, establishing a reliable protocol for genotoxicity testing. The developed method enhances the scope of the cytokinesis-block micronucleus test for chemical safety assessments.
Area of Science:
- Toxicology
- Genetics
- Cell Biology
Background:
- The in vitro micronucleus assay is crucial for assessing chemical genotoxicity.
- A standardized protocol for mouse fibroblast L929 cells was lacking.
Purpose of the Study:
- To optimize and validate the cytokinesis-block micronucleus (CBMN) test for L929 cells.
- To establish a reliable protocol for genotoxicity studies in this cell line.
Main Methods:
- Optimization of cytochalasin B concentration and positive controls (MMS, colchicine, CP).
- Evaluation of phenobarbital/5,6-benzoflavone as an S9 inducer.
- Testing of three exposure regimens and assessment of reproducibility.
- Identification of optimal staining methods (Giemsa, acridine orange).
Main Results:
- 1 μg/mL cytochalasin B and specific concentrations of MMS, colchicine, and CP were effective.
- Phenobarbital/5,6-benzoflavone proved superior to Aroclor 1254 as an S9 inducer.
- The developed protocol demonstrated reliable results and reproducibility.
Conclusions:
- A validated CBMN assay protocol for L929 cells was established.
- This protocol is suitable for genotoxicity testing according to OECD Guideline #487.
- The optimized assay expands the utility of micronucleus testing in chemical safety evaluations.
Related Concept Videos
Introduction to Fibroblasts
Clinical Applications of Epidermal Stem Cells
In-vitro Mutagenesis
Photoluminescence: Applications
Radiation: Applications
The average...
Applications of Stress
The...

